WO2023139626 - THERAPY OF INTEROCEPTION DISORDERS WITH CGRP RECEPTOR ANTAGONISTS
National phase entry is expected:
Publication Number
WO/2023/139626
Publication Date
27.07.2023
International Application No.
PCT/IT2023/050017
International Filing Date
19.01.2023
Title **
[English]
THERAPY OF INTEROCEPTION DISORDERS WITH CGRP RECEPTOR ANTAGONISTS
[French]
THERAPIE DE TROUBLES DE L'INTÉROCEPTION AVEC DES ANTAGONISTES DU RÉCEPTEUR DE CGRP
Applicants **
CHIARUGI, Alberto
Via di Serpiolle 5
50141 Firenze, IT
Inventors
CHIARUGI, Alberto
Via di Serpiolle 5
50141 Firenze, IT
Priority Data
102022000000869
20.01.2022
IT
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 980 | |
| EPO | Filing, Examination | 3571 | |
| Japan | Filing | 592 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 3235 |
Total: 8953 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Interoception is the mechanism by which an individual is informed about the status of its own body. When interoception becomes dysfunctional, it turns into a deleterious event for the health status of an individual. The use of calcitonin gene-related peptide (CGRP) receptor antagonists (gepants) for the treatment and 70 prevention of interoception disorders is described.[French]
L'intéroception est le mécanisme par lequel un individu est informé de l'état de son propre corps. Lorsque l'intéroception devient dysfonctionnelle, elle devient délétère pour l'état de santé d'un individu. L'invention concerne l'utilisation d'antagonistes du récepteur du peptide lié au gène de la calcitonine (CGRP) (gepants) pour le traitement et la prévention des troubles de l'intéroception.